Advanced Cell concludes an early-stage trial of its myoblast program

09/29/2010 | Mass High Tech (Boston)

Advanced Cell Technology plans to launch a midstage trial of its myoblast therapy during the first half of 2011, after finishing a Phase I study in heart failure patients. The Phase II trial will test the myoblast program, which involves the use of adult progenitor stem cells derived from a biopsy of skeletal muscle, in patients who are not fit to undergo bypass surgery or angioplasty.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of Massachusetts
Boston, MA
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide